Category Medicine and Healthcare
Press Release
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
Randomized, double-blind, placebo-controlled trial will evaluate two doses of the first-in-class, minimally absorbed SGLT1 inhibitor in patients with recurrent hypoglycemia following bariatric surgery Read More
Press Release
Jaguar Health Provides Update Regarding Special Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives Jaguar's rare disease intestinal failure development program for microvillus inclusion disease (MVID) and short bowel syndrome for crofelemer powder for oral solution is expected to continue to provide clinical milestones, including a planned New Drug Application (NDA) filing for crofelemer for MVID in mid-2027 Read More
Press Release
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for SBS-IF and microvillus inclusion disease (MVID) for crofelemer powder for oral solution, targeting a mid-2027 NDA filing for MVID Read More
Press Release
Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
Executive with three decades of life sciences financing and M&A experience joins the board as Lobe advances L-130 in anxiety and cluster headache and S-100 in sickle cell disease Read More
Press Release
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives Jaguar's rare disease intestinal failure development program for microvillus inclusion disease (MVID) and short bowel syndrome for crofelemer powder for oral solution is expected to continue to provide clinical milestones, including a planned New Drug Application (NDA) filing for crofelemer for MVID in mid-2027 Read More
Press Release
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's off-the-shelf regenerative technology GelrinC is CE Mark approved in Europe, where Regentis is expanding its network of Centers of Excellence to support surgeon training and commercialization efforts European clinical sites also support the Company's ongoing U.S. FDA pivotal Phase III trial Read More
Press Release
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Thirty-year biopharmaceutical commercial leader transitions from the Board of Directors to Chief Commercial Officer Appointment strengthens corporate strategy, business development and commercial readiness as the Company advances mizagliflozin following its August 2026 initial public offering Read More
Press Release
Vituity Cares Brings Music and Purpose to Nashville With Benefit Concert at Cannery Hall
Demola, Elijah Scott, Coey Redd, DJ Delano, Trew the Star, and Jeffrey ‘Sax' Stevenson come together for a special evening of live music supporting Vituity Cares' mission to expand access to care and strengthen communities Read More
Press Release
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027 A recent Rareatives article shares the story of a young child living with MVID, highlighting the importance of family perspectives, supportive communication, and collaboration with clinicians in addressing rare intestinal diseases Read More
Press Release
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities
Acquisition adds proven PzF™ thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility Read More
Press Release
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS-IF for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027 Read More
Press Release
Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants
Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces. Read More
Press Release
As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern "Heady" Burnout
Addressing the growing demand for non-psychedelic micro-rituals, Sacred Connection bridges ancestral Amazonian preparations with North America's microdosing and flow-state communities. Read More
Press Release
ACU-Serve and Tennr Partner to Transform Front-End Operations for Post-Acute Care Providers
Partnership combines Tennr's patient orchestration technology with ACU-Serve's revenue cycle expertise to help providers scale, improve intake efficiency and move patients to care faster. Read More
Press Release
Sacred Connection Launches Ancestral Pre-Meditation Ritual to Eliminate Cognitive Friction and Accelerate Stillness
Bridging ancient Amazonian botanicals with modern mindfulness practices, Sacred Connection offers a fast-acting grounding tool to quiet internal noise before meditation sits. Read More
Press Release
Jaguar Health Receives Fee Waivers from FDA
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027 Read More
Press Release
Vogenx Appoints Ken Toombs to Board of Directors
Former Chief Executive Officer of PA Consulting brings three decades of global professional services and life sciences leadership experience Appointment broadens independent oversight as the Company scales operations following its August 2026 initial public offering Read More
Press Release
Sacred Connection Introduces Ancestral Amazonian Protocol for Chronic Sinus Pressure and Tension Headaches
Offering a natural, plant-based alternative to chemical decongestants and pain relievers, Sacred Connection brings direct-trade botanical preparations to those seeking rapid head and sinus relief. Read More
Press Release
Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects
Combining radical supply-chain transparency with direct non-profit action, Sacred Connection funds clean water infrastructure, cultural preservation, and land stewardship across Huni Kuin, Yawanawá, and Katukina villages. Read More
Press Release
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16 ● Presentation covers Phase 1a first-in-human results for Conjugated Psilocin™ (L-130), including oral bioavailability, dose consistency and the absence of hallucinogenic effects at low doses ● Lobe to exhibit throughout the summit, September 15-17, alongside senior discovery, clinical and business development leaders from major pharmaceutical companies Read More
Press Release
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Advances GelrinC® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026 Expands European commercialization readiness, including surgeon training and regulatory approval of new manufacturing process that improves production yield 400% Strengthened balance sheet with $6.5 million private placement in June 2026 Read More
Press Release
Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide
This private, veteran-only retreat will offer medically supervised plant medicine treatment and long-term integration support for veterans living with treatment-resistant PTSD Read More
Press Release
Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout
Bridging ancestral Amazonian wisdom with modern somatic wellness, Sacred Connection introduces ethically sourced Hapé blends designed to reset overstimulated minds in 60 seconds. Read More
Press Release
The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor
The physician-led longevity and regenerative medicine practice is opening its first clinic in the Orlando area and is now accepting patients for the waitlist ahead of its September 28 opening. Read More
Press Release
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to file an NDA in mid-2027 for MVID, an ultrarare pediatric disease Read More
Press Release